Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2020 Jun 25;202(14):e00120-20. doi: 10.1128/JB.00120-20

Role of Glutamate Synthase in Biofilm Formation by Bacillus subtilis

Tan Kimura a, Kazuo Kobayashi a,
Editor: George O’Tooleb
PMCID: PMC7317036  PMID: 32393519

Bacillus subtilis, a model organism for bacterial biofilm formation, forms robust biofilms in a medium-dependent manner. Although the regulatory network that controls biofilm formation has been well studied, the importance of the underlying metabolic systems remains to be elucidated. The present study demonstrates that a metabolic disorder in a well-conserved metabolic system causes accumulation of an inhibitory metabolic intermediate that prevents activation of the system that regulates biofilm formation. These findings increase our understanding of the coordination between cellular metabolic status and the regulatory networks governing biofilm formation.

KEYWORDS: Spo0A, TCA cycle, biofilms, citrate, glutamate synthase, iron

ABSTRACT

Bacillus subtilis forms robust biofilms in the presence of large amounts of carbon sources, such as glycerol. However, little is known about the importance of the metabolic systems, or the relationship between metabolic systems and regulatory systems, involved in biofilm formation. Glutamate synthase, encoded by gltAB, is an enzyme that converts 2-ketoglutarate (a tricarboxylic acid [TCA] cycle intermediate) and glutamine into glutamate, which is a general amino group donor in metabolism. Here, we show that a ΔgltA mutant exhibited early arrest of biofilm formation in complex medium containing glycerol. This phenotype was not due to glutamate auxotrophy. Consistent with its biofilm formation phenotype, the ΔgltA mutant exhibited an early decrease in expression of the epsA and tapA operons, which are responsible for production of biofilm matrix polymers. This resulted from decreased activity of their regulator, Spo0A, as evidenced by reduced expression of other Spo0A-regulated genes in the ΔgltA mutant. The ΔgltA mutation prevented biofilm formation only in the presence of large amounts of glycerol. Moreover, limited expression of citrate synthase (but not other TCA enzymes) restored biofilm-forming ability to the ΔgltA mutant. These results indicate that the ΔgltA mutant accumulates an inhibitory intermediate (citrate) in the TCA cycle in the presence of large amounts of glycerol. The ΔgltA mutant formed biofilms when excess iron was added to the medium. Taken together, the data suggest that accumulation of citrate ions by the ΔgltA mutant causes iron shortage due to chelation, which prevents activation of Spo0A and causes defective biofilm formation.

IMPORTANCE Bacillus subtilis, a model organism for bacterial biofilm formation, forms robust biofilms in a medium-dependent manner. Although the regulatory network that controls biofilm formation has been well studied, the importance of the underlying metabolic systems remains to be elucidated. The present study demonstrates that a metabolic disorder in a well-conserved metabolic system causes accumulation of an inhibitory metabolic intermediate that prevents activation of the system that regulates biofilm formation. These findings increase our understanding of the coordination between cellular metabolic status and the regulatory networks governing biofilm formation.

INTRODUCTION

In the natural environment, most bacteria attach to biotic or abiotic surfaces, forming surface-associated multicellular communities called biofilms (1). Bacterial cells within biofilms adhere to each other and to surfaces via a matrix of extracellular polymeric substances called a biofilm matrix, which usually consists of exopolysaccharides, proteins, nucleic acids, and/or lipids (2, 3). The biofilm matrix not only supports biofilms structurally but also provides a physical and chemical barrier to member cells, thereby protecting them against environmental stresses, antibiotics, and attack by host immune systems (4, 5). In addition to producing extracellular polymeric substances, biofilm-forming cells express sets of genes different from those of planktonic cells (69); these include metabolic genes, some of which play unique roles in biofilms (1012). However, the importance of the metabolic systems that facilitate biofilm formation remains unclear.

Undomesticated strains of the Gram-positive bacterium Bacillus subtilis form robust biofilms, for example, heavily wrinkled pellicles on the surface of liquid medium under static culture conditions and morphologically complex colonies on solid medium (13). B. subtilis biofilms are maintained by a biofilm matrix that consists mainly of exopolysaccharides, TasA amyloid fibers, and BslA hydrophobins, which are produced by proteins encoded by the 15-gene operon epsABCDEFGHIJKLMNO (here referred to as the epsA operon), the tapA-sipW-tasA operon (here referred to as the tapA operon), and bslA, respectively (1318). These genes are directly or indirectly repressed by the transcriptional repressors AbrB and SinR (1922). Phosphorylation of the response regulator Spo0A is required to initiate biofilm formation; that is, phosphorylated Spo0A (Spo0A∼P) represses abrB transcription and induces expression of the proteins SinI and SlrR, which antagonize SinR (2328). Moreover, the two-component system DegS-DegU and the transcriptional activator RemA are required to induce transcription of these biofilm matrix genes (17, 2931). Thus, the regulatory network that controls B. subtilis biofilm formation is complex and involves multiple transcriptional regulators.

In addition to biofilm formation, Spo0A governs multiple cellular processes that occur during different growth periods (32). These processes include cannibalism and sporulation (reference 32 and references therein). Differential expression of Spo0A-regulated genes appears to occur because Spo0A-regulated genes have promoters with different affinities for Spo0A∼P (33). Specifically, low levels of Spo0A∼P repress abrB and induce sinI (to stimulate biofilm formation), as well as the skfA and sdpA operons (to stimulate cannibalism toxin production), whereas high levels of Spo0A∼P induce expression of genes that drive sporulation, including the spoIIA and spoIIG operons that encode sporulation-specific sigma factors (reference 33 and references therein). Four sensor histidine kinases (KinA, KinB, KinC, and KinD) phosphorylate Spo0A via a multicomponent phosphotransfer system known as the phosphorelay, in which phosphoryl groups from autophosphorylating sensor kinases are transferred successively to relay proteins Spo0F and Spo0B and, finally, to Spo0A (3437). These sensor kinases appear to play distinct roles. Specifically, KinC and KinD are responsible for production of low levels of Spo0A∼P (37, 38), which are enough to induce biofilm formation and cannibalism toxin production (33, 3941), whereas KinA and KinB are responsible for production of high levels of Spo0A∼P, which are required to induce sporulation (36). However, the functional differences between these kinases are not strict, and they vary according to nutrient conditions (38, 42). In addition, cellular levels of Spo0A∼P are controlled by multiple regulators, including phosphatases and the Fe-S cluster-containing RicAFT protein complex (4349).

Biofilm formation is a consumptive process, as it is accompanied by production and secretion of large amounts of extracellular polymeric substances. Biofilm formation by B. subtilis is a medium-dependent process. Media supporting B. subtilis biofilm formation contain 0.5% to 1% carbon sources that can be consumed through glycolysis, and these sugars are necessary for robust biofilm formation (13, 5052). In addition to sugars, glutamate or glutamine is essential to support biofilm formation in synthetic medium, even though B. subtilis strains have no auxotrophy for glutamate and glutamine (53). These requirements suggest that metabolic systems play critical roles in biofilm formation. However, despite our current understanding of the regulatory networks governing B. subtilis biofilm formation, little is known about the importance of the metabolic systems or the relationship between regulatory networks and these metabolic systems. This is, in part, because defects in metabolic systems often cause a growth defect, particularly in synthetic medium in which biofilm formation by B. subtilis has been analyzed frequently. During biofilm formation, carbon sources are consumed by glycolysis (Fig. 1). Since genes involved in the tricarboxylic acid (TCA) cycle and nitrogen metabolism are induced during biofilm formation (9), some of its metabolites flow into the TCA cycle and then nitrogen metabolism. Glutamate synthase (also known as glutamine oxoglutarate aminotransferase [GOGAT]), a two-subunit enzyme encoded by gltAB, connects the TCA cycle with nitrogen metabolism by converting each molecule of 2-oxoglutarate and glutamine into two molecules of glutamate (54). The glutamine required for this reaction is synthesized from glutamate and ammonium by glutamine synthetase (GS). The reactions of GS and GOGAT form one cycle, which serves as a main route of ammonium assimilation, and its product, glutamate, serves as a general amino group donor during biosynthesis of nitrogen-containing compounds such as amino acids, nucleotides, and polyamines (5456). Glutamate, which is normally the cell’s most abundant amino acid, also plays important roles in cellular physiology (56). Since in B. subtilis, glutamate dehydrogenases (GDH) are devoted to glutamate degradation and are not involved in its biosynthesis, glutamate synthase (GOGAT) is a main contributor to ammonium assimilation and glutamate biosynthesis (54, 56). In addition to the de novo biosynthetic pathway, glutamate is synthesized by amino acid degradation under conditions of nutrient depletion (57).

FIG 1.

FIG 1

Simplified metabolic pathways for carbon and nitrogen metabolism. The enzymes described in the text are shown along with their corresponding gene names in blue. Glutamate synthase is shown in red. Abbreviations: CS, citrate synthase; ACN, aconitase, IDH, isocitrate dehydrogenase; MDH, malate dehydrogenase; FUM, fumarase; GOGAT, glutamate synthase; GS, glutamine synthase; GDH, glutamate dehydrogenase.

A previous report shows that a transposon insertion in gltA impairs biofilm formation in nutrient-rich complex medium (58). The glutamate auxotrophy of the ΔgltA mutant in that study did not appear to be the cause of the biofilm formation defect, as addition of glutamate did not restore biofilm formation to the ΔgltA mutant (58). We were interested in these ΔgltA mutant phenotypes because these observations seem to suggest that an unknown mechanism involved in integrating the cellular metabolic status into the regulatory network for biofilm formation might underlie the ΔgltA mutant phenotype. Moreover, since the ΔgltA mutation disturbs both carbon and nitrogen metabolism, its effect on biofilm formation is also intriguing. However, since analysis of the ΔgltA mutant in that study was performed under conditions unsuitable for biofilm formation using a domesticated strain (58), which forms biofilms poorly (59), the ΔgltA mutant phenotype must be verified under appropriate conditions using undomesticated strains that form robust biofilms. Here, we investigated the effect of the ΔgltA mutation on biofilm formation by an undomesticated strain. Based on our findings, we propose how the ΔgltA mutation causes a defect in biofilm formation.

RESULTS

The ΔgltA mutation prevents biofilm formation.

To test its effect on biofilm formation on an undomesticated strain background, we introduced the ΔgltA mutation into strain NCIB3610 (here referred to as the wild-type strain) (13), which is used widely for biofilm formation studies. We tested the ability of the ΔgltA mutant to form biofilms in nutrient-rich complex medium, 2× SGG (51). When grown statically in liquid 2× SGG, the wild-type strain formed thin pellicles on the surface of the medium 24 h after inoculation and thick, heavily wrinkled pellicles at 48 h (Fig. 2). The ΔgltA mutant formed thin pellicles at 24 h (like the wild-type strain) but failed to develop thick pellicles; the ΔgltA mutant only formed thin, flat pellicles at 48 h. On solid 2× SGG medium, the wild-type strain formed structurally complex colonies at 48 h, which comprised a central area fully covered with tiny wrinkle structures and a prominent peripheral area surrounding the central area (Fig. 2). The central area of colonies is the footprint of where the founding cells are deposited and therefore contains older organisms than the peripheral expanding zone does. Its morphological features resemble those of pellicle biofilms; the heavily wrinkled structures in the central area appeared to represent mature biofilms. Unlike the wild-type strain, the ΔgltA mutant formed colonies with no wrinkles in the central areas at 48 h (Fig. 2). The thin and flat features within the central area of the ΔgltA mutant colonies were consistent with the thin, flat pellicles of the ΔgltA mutant. The biofilm formation-defective phenotype of the ΔgltA mutant was also observed in MSgg synthetic medium, which contains glutamate as a nitrogen source (13). On solid MSgg medium, the wild-type strain formed whitish colonies covered with wrinkles, whereas the ΔgltA mutant formed brownish colonies with tiny wrinkles only in the central areas (see Fig. S1 in the supplemental material).

FIG 2.

FIG 2

The ΔgltA mutation causes early arrest of biofilm formation. Wild-type and ΔgltA mutant strains were grown statically in liquid 2× SGG medium in 6-well plates (“pellicle”) and on solid 2× SGG medium (“colony”). Top-down views of entire biofilms are shown. Magnified images of biofilms taken at 48 h with a stereomicroscope (see right side of each series of photos). A well without bacteria inoculated (“medium”) is shown as a reference. Scale bars, 5 mm.

Next, we confirmed that the biofilm formation-defective phenotypes of the ΔgltA mutant were not due to a growth defect caused by glutamate auxotrophy, although 2× SGG medium contains plenty of glutamate. According to the Difco & BBL manual (https://www.bd.com/resource.aspx?IDX=9572), the medium contains about 1.2% glutamate. Wild-type and ΔgltA mutant strains were grown with vigorous shaking in liquid 2× SGG, and the optical density at 600 nm (OD600) and pH of the cultures were compared over time. As shown in Fig. 3, there was no difference in growth between the wild-type and ΔgltA mutant strains, at least from the exponential to early stationary phases. However, the pH in these cultures was different. Specifically, the pH of the wild-type strain culture fell as it grew, reaching 5.8 at the end of the exponential phase (Fig. 3A). This decrease in pH is likely to be due to production of acidic glycolytic products such as acetate, lactate, and pyruvate (Fig. 1). The pH then increased slightly and transiently but decreased gradually again (to pH 5.5); subsequently, it increased to 7.0. This increase is probably caused by the production of ammonium due to consumption of amino acids in the medium. The ΔgltA mutant exhibited a decrease in pH similar to that of the wild-type strain during the exponential phase; however, the pH began to increase immediately after the end of the exponential phase. This earlier increase in pH suggests that the ΔgltA mutation hastens the onset of amino acid consumption to compensate for the glutamate shortage. Similar pH changes were observed in standing cultures, but the changes were slower and more moderate than those in shaking cultures (Fig. S2A). In standing culture, pH in wild-type and ΔgltA mutant cultures fell to 6.1 and then gradually increased. During the increase, the ΔgltA mutant culture exhibited higher pH than the wild-type strain culture. However, the increase in pH of the ΔgltA mutant culture almost stopped at 38 h, probably because the ΔgltA mutant stopped biofilm formation. Thus, the ΔgltA mutation alters the activity of nitrogen metabolism pathways but does not affect growth in 2× SGG complex medium. These results indicate that the ΔgltA mutation causes early arrest of biofilm formation in 2× SGG medium, although this is unlikely to be due to a defect in growth.

FIG 3.

FIG 3

The glutamate auxotrophy of the ΔgltA mutant is not the cause of its biofilm formation defect. Growth and pH profiles of the wild-type and ΔgltA mutant strains are shown. The wild-type strain and the ΔgltA mutant were grown in 2× SGG at 37°C with vigorous shaking, and the OD600 and pH of the cultures were compared over time.

Decreased expression of the eps and tapA operons is responsible for the biofilm formation defect of the ΔgltA mutant.

B. subtilis biofilms are supported by exopolysaccharides and TasA amyloid fibers, which are synthesized by the products of the epsA and tapA operons, respectively (1316). Therefore, we hypothesized that the ΔgltA mutation might affect transcription of these operons. To analyze the promoter activity of these operons, we used the green fluorescent protein (GFP) as a transcriptional reporter and introduced the PepsA-gfp or PtapA-gfp reporter into the chromosomes of the wild-type and ΔgltA mutant strains. The wild-type and ΔgltA mutant strains harboring the PepsA-gfp or PtapA-gfp reporters were grown statically in liquid medium, and expression of the reporters in individual cells was analyzed using flow cytometry. The wild-type strain lacking gfp reporters was used as a negative control. The wild-type and ΔgltA mutant strain harboring PepsA-gfp exhibited very similar, homogeneous expression of GFP at 24 h; however, this then became different (Fig. 4, upper row). Specifically, wild-type cells continued to express GFP even at 72 h, whereas ΔgltA mutant cells showed reduced GFP expression at 48 h. The PtapA-gfp reporter was expressed in a manner similar to the PepsA-gfp reporter; ΔgltA mutant cells exhibited lower expression of GFP from PtapA-gfp than wild-type cells at 48 and 72 h (Fig. 4, lower row). Thus, the ΔgltA mutation causes an early decrease in transcription of the eps and tapA operons during biofilm formation, which is consistent with its biofilm formation phenotype.

FIG 4.

FIG 4

The ΔgltA mutation causes an early decrease in transcription of epsA and tapA operons. Strains harboring the PepsA-gfp or PtapA-gfp reporter were grown statically in 2× SGG, and expression of GFP in individual cells was analyzed using flow cytometry. The wild-type strain lacking the gfp reporter was used as a negative control.

Next, we examined whether increased transcription of the eps and tapA operons restored biofilm formation to the ΔgltA mutant. Transcription of these operons is negatively and independently regulated by two repressors, AbrB and SinR (1921). Introducing the ΔabrB or ΔsinR mutation restored biofilm formation to the ΔgltA mutant (Fig. 5A). Moreover, we introduced the isopropyl-β-d-1-thiogalactopyranoside (IPTG)-inducible, LacI-repressible promoter spac-hy (60) upstream of epsA or tapA; then, the Pspac-hy-eps operon and Pspac-hy-tapA operon constructs were transferred to the ΔgltA mutant. The Pspac-hy-eps operon and Pspac-hy-tapA operon strains formed biofilms only in the presence of IPTG, although the pellicles of the Pspac-hy-tapA operon strain were somewhat rough (Fig. 5B). Induction of either the eps operon or the tapA operon from the spac-hy promoter with IPTG restored biofilm formation to the ΔgltA mutant. These results indicate that decreased transcription of the eps and tapA operons is responsible for the biofilm formation defect of the ΔgltA mutant.

FIG 5.

FIG 5

Reduced expression of epsA and tapA operons is responsible for the biofilm formation defect in the ΔgltA mutant. (A) ΔabrB and ΔsinR mutations suppress the ΔgltA mutation during biofilm formation. Pellicle biofilms grown for 48 h are shown. (B) Induction of the epsA or tapA operons restores biofilm formation to the ΔgltA mutant. The Pspac-hy-epsA operon and Pspac-hy-tapA operon strains were grown for 48 h with or without 1 mM IPTG. Scale bars, 5 mm.

The ΔgltA mutation reduces transcription of Spo0A-regulated genes.

Transcription of the eps and tapA operons requires phosphorylated Spo0A, which represses abrB transcription and induces antagonistic proteins specific for SinR (2328). Therefore, we asked whether the ΔgltA mutation affects transcription of Spo0A-regulated genes skfA and spoIIAA (33). Flow cytometry showed that transcription of PskfA-gfp and PspoIIA-gfp in the wild-type and ΔgltA mutant strains was induced at 48 h, but expression of both was clearly lower in the ΔgltA mutant (Fig. 6A). Since the spoIIA operon encodes the sporulation-specific sigma factor σF, decreased transcription of the spoIIA operon should lead to a decrease in sporulation. To test this, we measured sporulation frequency in pellicles at 72 h. As shown in Fig. 6B, 21.7% of wild-type cells formed spores in pellicles, whereas only 3.4% of the ΔgltA mutant cells did. Thus, consistent with the small decrease in spoIIA transcription, the ΔgltA mutant produced 6.3-fold fewer spores than the wild-type strain. These results indicate that the ΔgltA mutation reduces Spo0A∼P levels, probably leading to decreased transcription of the epsA and tapA operons.

FIG 6.

FIG 6

The ΔgltA mutation reduces transcription of Spo0A-regulated genes. (A) Expression of the PskfA-gfp and PspoIIA-gfp reporters was analyzed using flow cytometry. The wild-type strain lacking the gfp reporter was used as a negative control. (B) Sporulation frequency of wild-type and ΔgltA mutant strains in pellicle biofilms. These strains were grown statically for 72 h, and the cultures were used to determine sporulation frequency. Data are expressed as the mean and standard deviation from three independent experiments.

The ΔgltA mutation inhibits the phosphorelay.

Cellular Spo0A∼P levels are positively controlled by four sensor kinases in the phosphorelay (3438). Therefore, we examined the possibility that the ΔgltA mutation inhibits the activity of a certain sensor kinase in the phosphorelay. As previously observed (39), the ΔkinC and ΔkinD mutations prevented biofilm formation in 2× SGG (Fig. S3). Likewise, the ΔkinC and ΔkinD mutations exacerbated the biofilm formation-defective phenotype of the ΔgltA mutant. These results indicate that, like the wild-type strain, formation of thin biofilms by the ΔgltA mutant depends on KinC and KinD. To examine KinC and KinD activity separately, we placed kinC or kinD under the control of the spac-hy promoter and deleted the other sensor kinase genes for the phosphorelay. The resultant strains, Pspac-hy-kinC ΔkinABD and Pspac-hy-kinD ΔkinABC strains, did not form pellicles in the absence of IPTG, but they did form pellicles (like the wild-type strain) in the presence of 30 μM IPTG, and they formed thicker pellicles in the presence of ≥100 μM IPTG (Fig. 7A). Thus, the Pspac-hy-kinC ΔkinABD and Pspac-hy-kinD ΔkinABC strains formed biofilms in a KinC- or KinD-dependent manner, respectively. To examine the effect of the ΔgltA mutation on KinC- or KinD-dependent biofilm formation, we introduced the ΔgltA mutation into these strains. If the ΔgltA mutation specifically inhibits either KinC or KinD, the ΔgltA mutation might prevent biofilm formation in one of the strains. However, the Pspac-hy-kinC ΔkinABD ΔgltA and Pspac-hy-kinD ΔkinABC ΔgltA strains both formed only thin pellicles (like the ΔgltA mutant) in the presence of 30 μM IPTG. Thus, the ΔgltA mutation did not inhibit KinC or KinD specifically. However, in the presence of ≥100 μM IPTG, the Pspac-hy-kinC ΔkinABD ΔgltA and Pspac-hy-kinD ΔkinABC ΔgltA strains formed thick pellicles, as did the Pspac-hy-kinC ΔkinABD and Pspac-hy-kinD ΔkinABC strains. Thus, overexpression of KinC or KinD fully restores biofilm formation to the ΔgltA mutation. These results indicate that the ΔgltA mutation prevents biofilm formation by reducing Spo0A∼P levels but that inhibition does not occur via activity of KinC or KinD.

FIG 7.

FIG 7

The ΔgltA mutation prevents phosphorelay. (A) The ΔgltA mutation does not inhibit KinC or KinD specifically. The Pspac-hy-kinC ΔkinABD and Pspac-hy-kinD ΔkinABC strains with or without the ΔgltA mutation were grown for 48 h in liquid 2× SGG supplemented with the indicated concentrations of IPTG. (B) Expression of Sda and Spo0E phosphatases by the ΔgltA mutant. Wild-type and ΔgltA mutant strains harboring the Psda-gfp or Pspo0E-gfp reporter were grown statically for 48 h in 2× SGG, and expression of these reporters was analyzed using flow cytometry. The wild-type strain lacking the gfp reporter was used as a negative control. Scale bars, 5 mm.

Cellular Spo0A∼P levels are also negatively controlled by multiple phosphatases (4345). Among these, sda and spo0E are regulated by LexA and the stress-responsive alternative sigma factor σB, which respond to DNA damage and environmental and metabolic stresses, respectively (45, 61, 62). We hypothesized that the ΔgltA mutation might induce some stress responses, leading to decreased expression of Spo0A∼P through the activity of Sda or Spo0E. To test this, we measured transcription of sda and spo0E. However, Psda-gfp and Pspo0E-gfp were expressed similarly in the wild-type and ΔgltA mutant strains (Fig. 7B). Thus, the ΔgltA mutation did not induce transcription of these phosphatase genes. Taken together, the results indicate that the ΔgltA mutation negatively affects a certain step in the phosphorelay but that this step does not relate to sensor kinases or phosphatases.

The defect in biofilm formation due to the ΔgltA mutation is dependent on large amounts of glycerol.

We sought to determine whether the metabolic change caused by the ΔgltA mutation led to decreased Spo0A∼P and, thereby, to a defect in biofilm formation. B. subtilis forms robust biofilms in 2× SGG medium in a manner dependent on large amounts of glucose and glycerol. These carbon sources are assimilated through glycolysis, and some of the metabolites flow into the TCA cycle and nitrogen metabolism (Fig. 1). Since glutamate synthase, encoded by gltAB, serves as a conduit from the TCA cycle to nitrogen metabolism, disruption of this conduit by the ΔgltA mutation could cause excess flow or accumulation of metabolic intermediates of carbon metabolism upstream of glutamate synthase as well as an inflow shortage to nitrogen metabolism downstream of glutamate synthase. The observation that 2× SGG medium contains plenty of glutamate and can support growth of the ΔgltA mutant suggested that an abnormal flow in carbon metabolism, rather than an inflow shortage in nitrogen metabolism, leads to the biofilm formation defect of the ΔgltA mutant. To test this hypothesis, we examined the effect of the concentration of carbon sources on biofilm formation by the wild-type and ΔgltA mutant strains. 2× SGG medium contains 0.1% glucose and 1% glycerol as primary carbon sources. To simplify the analysis, we removed these carbon sources and added various concentrations of glycerol instead. When grown statically in liquid medium, the wild-type strain formed only very thin pellicles in the absence of glycerol; however, it formed thicker wrinkled pellicles as the concentration of glycerol increased (Fig. 8). On solid medium in the absence of glycerol, the wild-type strain formed colonies with only a few wrinkles in the central areas but formed colonies with more and larger wrinkles as the concentration of glycerol increased. The ΔgltA mutant formed pellicles and colonies similar to those of the wild-type strain in the absence or presence of 0.1% glycerol. However, addition of higher concentrations of glycerol inhibited rather than promoted biofilm formation by the ΔgltA mutant. The negative effect of high concentrations of glycerol was more pronounced with respect to colony biofilm formation; in the presence of 0.5% and 1% glycerol, the ΔgltA mutant formed colonies with no wrinkles in the central areas. Thus, the ΔgltA mutant exhibited a defect in biofilm formation that was dependent on high concentrations of glycerol. These results support our hypothesis that the ΔgltA mutation causes abnormal carbon metabolism, leading to a biofilm formation defect. We also tested the effect of glucose on biofilm formation. However, the high concentration of glucose did not stimulate biofilm formation even in the wild-type strain (Fig. 8), probably because biofilm formation is subject to catabolite repression (63).

FIG 8.

FIG 8

ΔgltA mutation-mediated prevention of biofilm formation is dependent on large amounts of glycerol. Wild-type and ΔgltA mutant strains were grown for 48 h in modified 2× SGG, which contained the indicated concentrations (percent [wt/vol]) of glycerol or glucose instead of 0.1% glucose and 1% glycerol. Magnified images of colony biofilms taken with a stereomicroscope are also shown. Scale bars, 5 mm.

The ΔgltA mutant causes a defect in biofilm formation due to the accumulation of citrate.

In the presence of large amounts of glycerol, large amounts of glycolytic metabolites are expected to flow into the TCA cycle; some of these metabolites are pumped from the TCA cycle to nitrogen metabolism by glutamate synthase (Fig. 1). Therefore, we hypothesized that the ΔgltA mutation might generate excessive accumulation of TCA cycle intermediates, leading to a biofilm formation defect. If this was the case, disrupting TCA cycle genes could restore biofilm formation to the ΔgltA mutant. The first and second enzymes in the TCA cycle are citrate synthase (CitZ and CitA) and aconitase (CitB) (64). B. subtilis possesses two citrate synthases, CitZ and CitA, but CitZ is responsible for the bulk of citrate synthase activity (65). To test our hypothesis, we deleted citZ and citB and tested the ability of the mutants to form biofilms. We found that the ΔcitZ and ΔcitB mutants formed only very thin pellicles in standing culture (Fig. S4), which made it difficult to test whether these mutations could improve biofilm formation by the ΔgltA mutant. To overcome this problem, we replaced the native promoters of TCA enzyme genes with the spac-hy promoter and examined whether the limited induction of TCA enzyme genes from the spac-hy promoter in the presence of low concentrations of IPTG could restore biofilm formation to the ΔgltA mutant. The Pspac-hy-citZ strain formed very thin pellicles in the absence of IPTG but formed thicker wrinkled pellicles as IPTG concentrations increased (Fig. 9). In the presence of 16 μM IPTG, the Pspac-hy-citZ strain formed pellicles comparable with those of the wild-type strain. The Pspac-citZ ΔgltA strain formed pellicles similar to the Pspac-citZ strain in the presence of 0 to 4 μM IPTG and formed wrinkled pellicles in the presence of 2 and 4 μM IPTG. However, its pellicle formation was clearly inhibited in the presence of ≥8 μM IPTG; the Pspac-citZ ΔgltA strain formed very thin pellicles (like the ΔgltA mutant) in the presence of 16 μM IPTG. Thus, limited expression of citZ restored biofilm formation to the ΔgltA mutant. We also tested the effect of limited expression of other TCA cycle genes, citB, citC, mdh, and citG (Fig. 1), on biofilm formation by the ΔgltA mutant. However, limited induction of these genes from the spac-hy promoter did not restore biofilm formation to the ΔgltA mutant; specifically, on the ΔgltA mutant background, the Pspac-hy-citB, Pspac-hy-citC, Pspac-hy-mdh, and Pspac-hy-citG strains did not form wrinkled pellicles at any of the IPTG concentrations tested. These results indicate that limited induction of citZ suppresses the ΔgltA mutation not by reducing the overall activity of the TCA cycle but by reducing CitZ activity, i.e., by reducing citrate production.

FIG 9.

FIG 9

Limited expression of citZ restores biofilm formation to the ΔgltA mutant. The indicated genes for the TCA cycle in the wild-type and ΔgltA mutant strains were placed under the control of the spac-hy promoter. These strains were grown statically for 48 h in 2× SGG supplemented with the indicated concentrations of IPTG. To make the wrinkle structures of pellicles easier to see, magnified images are shown. Full images of the pellicles are shown in Fig. S5. Scale bars, 5 mm.

Addition of excess iron suppresses the ΔgltA mutant phenotype.

The results obtained thus far suggest that ΔgltA mutant cells probably accumulate citrate, which prevents biofilm formation. Since accumulated citrate can chelate cellular divalent metal ions (77), we examined the possibility that the biofilm formation defect of the ΔgltA mutant was due to chelation of metal ions important for biofilm formation by citrate ions. Since iron and manganese stimulate biofilm formation (52, 6668), we examined whether the addition of excess iron or manganese might improve biofilm formation by the ΔgltA mutant. Wild-type and ΔgltA mutant strains were grown in medium containing a 5-fold, 25-fold, or 125-fold excess of FeSO4 or MnCl2 relative to that in 2× SGG medium. In the presence of a 25-fold or 125-fold excess of FeSO4, the ΔgltA mutant formed wrinkled pellicles (Fig. 10A). As described above, an increase in pH of the ΔgltA mutant culture stopped when the ΔgltA mutant arrested biofilm formation. In the presence of a 125-fold excess of FeSO4, the pH of the ΔgltA mutant culture continued to increase as observed for that of the wild-type strain culture (Fig. S2B). Although we could not test the effect of a 25-fold or 125-fold excess of MnCl2 due to inhibitory effects on biofilm formation, a 5-fold excess of MnCl2 did not improve biofilm formation by the ΔgltA mutant. These results are supportive of the conclusion that in the ΔgltA mutant, accumulated citrate causes an iron shortage, leading to a biofilm formation defect.

FIG 10.

FIG 10

Excess iron suppresses the ΔgltA mutation during biofilm formation. (A) Wild-type and ΔgltA mutant strains were grown statically for 48 h in modified 2× SGG supplemented with the indicated concentrations of FeSO4 or MnCl2 instead of 1 μM FeSO4 or 0.1 mM MnCl2. The relative ratios of FeSO4 or MnCl2 concentrations to that in original 2× SGG medium are also shown. (B) Effect of iron limitation on biofilm formation. The wild-type strain was grown on modified 2× SGG medium supplemented with 1/10 FeSO4 or without FeSO4. Scale bars, 5 mm.

To test the requirement of iron for biofilm formation, the wild-type strain was grown in 2× SGG medium without added FeSO4. Note that because the nutrient broth in 2× SGG contains a trace of iron, no added FeSO4 does not equate to zero iron. Not adding FeSO4 had no significant effect on pellicle formation (Fig. S6). However, the wild-type strain formed colonies with no wrinkles in the central areas on solid medium containing 1/10 or no additional FeSO4, as observed for ΔgltA mutant colonies on normal 2× SGG (Fig. 10B). This result suggests that a shortage of iron can prevent biofilm formation.

DISCUSSION

Glutamate synthase is a key enzyme that connects carbon and nitrogen metabolism. Here, we demonstrate that the ΔgltA mutation caused early arrest of biofilm formation in nutrient-rich 2× SGG medium. Unexpectedly, this defect was not caused by disruption of some important metabolic systems that underlie biofilm formation; indeed, artificial expression of either the epsA or tapA operon restored biofilm formation to the ΔgltA mutant. Instead, the ΔgltA mutation interferes with the regulatory system for biofilm formation. Our results indicate that the ΔgltA mutant probably accumulates an inhibitory metabolic intermediate, citrate. The accumulated citrate reduces cellular iron levels, which prevent phosphorylation of Spo0A∼P, leading to reduced expression of the epsA and tapA operons.

B. subtilis biofilm formation depends on large amounts of carbon sources such as glycerol. We propose the following scenario for carbon metabolism and the function of glutamate synthase during biofilm formation. Since acetoin synthesis is required for biofilm formation under our culture conditions (51), B. subtilis cells grow with overflow metabolism during an early phase of biofilm formation (Fig. 1). This is probably the reason why the ΔgltA mutant did not exhibit a biofilm formation defect for the first 24 h. Subsequently, glycolytic metabolites pyruvate and acetyl coenzyme A (acetyl-CoA) flow into the TCA cycle, and citrate synthase converts these compounds into citrate. Citrate inhibits the transcriptional repressor CcpC, thereby derepressing its target genes (the citZ operon and citB) (69). The gene products (citrate synthase, aconitase, and isocitrate dehydrogenase) together increase production of 2-ketoglutarate, an inducer of the transcriptional regulator GltC, which activates gltAB transcription (70). Previous studies demonstrate that GltC activity is inhibited directly by glutamate, even in the presence of 2-ketoglutarate (70). Moreover, in the presence of glutamate, GltC is sequestered by moonlighting proteins the glutamate dehydrogenases RocG and GudB (71, 72). These mechanisms are predicted to keep GltC inactive and to keep gltAB transcription at low levels in 2× SGG medium, which contains plenty of glutamate and other amino acids. However, given that the ΔgltA mutant probably accumulates citrate, a substantial amount of 2-ketoglutarate in the wild-type strain is converted to glutamate by glutamate synthase. Thus, these existing regulatory mechanisms for controlling gltAB transcription do not seem to fully explain the phenomena observed herein. These regulatory models are constructed based on experiments in which biofilm formation-deficient, domesticated strains were grown in synthetic medium under non-biofilm formation conditions (7072). Recently, Pisithkul et al. (9) reported a comprehensive analysis of the transcription of metabolic genes and the dynamics of metabolic systems during biofilm formation by an undomesticated strain. Although their analysis was carried out using synthetic medium supplemented with glutamate, transcription of gltAB was induced during biofilm formation. These observations suggest that gltAB is specifically induced during biofilm formation through unknown mechanisms and plays important roles in biofilms. One possible function for active glutamate synthase is to provide materials that allow biosynthesis of nitrogen-containing compounds to be well-coordinated with robust growth of biofilm-forming cells. However, since the ΔgltA mutant expressing the epsA or tapA operon was able to form robust biofilms comparable with those of the wild-type strain, glutamate synthase activity seems to be excessive. We therefore propose that B. subtilis biofilm-forming cells employ a mechanism that sends excessive metabolites from the TCA cycle to nitrogen metabolism to generate storage compounds. This mechanism may prevent metabolites from accumulating in carbon metabolic pathways and stimulate carbon assimilation. B. subtilis produces poly-γ-glutamate in biofilms (50). The cellular levels of some amino acids and nucleotides, which are produced from glutamate, increase during biofilm formation (9). These can be considered storage compounds. Often, bacteria in biofilms compete with other species for space and nutrients. The ability to assimilate favorable nutrients more ravenously than other bacteria and then produce some storage compounds may confer B. subtilis with a competitive advantage within biofilms. Future studies should explore the possibility that three enzymes of the TCA cycle branch (citrate synthase, aconitase, and isocitrate dehydrogenase) and glutamate synthase play important roles in cell competition and survival within biofilms.

A previous study reports that the phosphorelay is inhibited by accumulated citrate (65). A null mutant of citB accumulated citrate and exhibited a severe defect in sporulation. However, the ΔgltA mutation had only a minor effect on sporulation compared with the ΔcitB mutation. This suggests that citrate levels in the ΔgltA mutant may be lower than those in the ΔcitB mutant and that biofilm formation may be much more sensitive to cellular citrate than sporulation. Aconitase encoded by citB is a bifunctional protein that also acts as an RNA-binding protein (73). Under low iron conditions, aconitase binds to the 5′ leader region of citZ mRNA and restricts the synthesis of citrate synthase. This mechanism likely suppresses accumulation of citrate to some extent in the ΔgltA mutant. Differences in sensitivity to citrate between sporulation and biofilm formation are probably due to the fact that these two processes have different requirements for Spo0A∼P. Low levels of Spo0A are enough to induce biofilm formation, whereas high levels of Spo0A∼P are required to induce sporulation (33). Therefore, the activity of the phosphorelay producing Spo0A∼P is much lower during biofilm formation, which can make biofilm formation more sensitive to inhibitors of the phosphorelay. Citrate ions can chelate divalent cations. Since addition of excess iron restored biofilm formation to the ΔgltA mutant, accumulated citrate probably causes an iron shortage in the ΔgltA mutant, which inhibits the phosphorelay. Since the ΔgltA mutant expressing the epsA or tapA operon was able to form robust biofilms, this iron shortage is not severe enough to inhibit growth. These observations suggest that some components of the phosphorelay are very sensitive to low levels of cellular iron. Possible targets for iron shortage are iron-containing proteins. The RicAFT protein complex carrying two [4Fe-4S]2+ clusters regulates biofilm formation and sporulation by accelerating the phosphorylation of Spo0A (4649). The respiratory chain is required for biofilm formation (12). Iron shortage may disrupt these functions during biofilm formation.

MATERIALS AND METHODS

Bacterial strains and media.

The B. subtilis strain NCIB3610 and its derivatives used in this study are listed in Table 1. Construction of B. subtilis mutants is described in the supplemental material. The primers used for the strain construction are listed in Table S1. Strains NRS2242 and NRS2394 were a kind gift from Nicola Stanley-Wall. B. subtilis strains were maintained in LB (LB Lennox; BD Difco, Franklin Lakes, NJ). Biofilm-forming ability was tested in 2× SGG medium, which comprises 1.6% (wt/vol) nutrient broth (BD Difco), 0.2% (wt/vol) KCl, 0.1% (wt/vol) glucose, 1% (wt/vol) glycerol, 2 mM MgSO4, 1 mM Ca(NO3)2, 0.1 mM MnCl2, and 1 μM FeSO4 (51). Escherichia coli strains JM105 and HB101 were used for construction and maintenance of plasmids.

TABLE 1.

B. subtilis strains used in this study

Strain Genotype Reference, source, or constructiona
NCIB3610 Prototroph 13
N694 ΔgltA::cat This study
N1802 ΔgltA::neo This study
NRS2242 ΔsacA::PepsA-gfp (kan) 75
N1823 ΔsacA::PepsA-gfp (kan) ΔgltA::cat N694 → NRS2242
NRS2394 ΔsacA::PtapA-gfp (kan) 75
N1824 ΔsacA::PtapA-gfp (kan) ΔgltA::cat N694 → NRS2394
N197 ΔabrB::kan W1050 (19) → NCIB3610
N695 ΔabrB::kan ΔgltA::cat N197 → N694
N976 ΔsinR::erm This study
N1823 ΔsinR::erm ΔgltA::cat N976 → N694
N901 epsA::pMutinT3-hy (Pspac-hy-epsA operon, tet) 76
N1835 epsA::pMutinT3-hy (Pspac-hy-epsA operon, tet) ΔgltA::neo N694 → N901
N1821 tapA::pMutinT3-hy (Pspac-hy-tapA operon, erm) This study
N1822 tapA::pMutinT3-hy (Pspac-hy-tapA operon, erm) ΔgltA::neo N694→N1821
N1659 ΔamyE::PskfA-gfp (tet) This study
N1873 ΔamyE::PskfA-gfp (tet) ΔgltA::cat N1659 → N694
N1658 ΔamyE::PspoIIA-gfp (tet) This study
N1875 ΔamyE::PspoIIA-gfp (tet) ΔgltA::cat N1658 → N694
N537 ΔkinC This study
N1829 ΔkinC ΔgltA::cat N694 → N537
N557 ΔkinD This study
N1830 ΔkinD ΔgltA::cat N694 → N557
N541 ΔkinA ΔkinB This study
N1827 ΔkinA ΔkinB ΔgltA::cat N694 → N541
N733 kinC::pMutinT3-hy (Pspac-hy-kinC operon, erm) ΔkinA ΔkinB ΔkinD This study
N1743 kinC::pMutinT3-hy (Pspac-hy-kinC operon, erm) ΔkinA ΔkinB ΔkinD ΔgltA::neo N1802 → N733
N635 kinD::pMutinT3-hy (Pspac-hy-kinD operon, erm) ΔkinA ΔkinB ΔkinC This study
N1744 kinD::pMutinT3-hy (Pspac-hy-kinD operon, erm) ΔkinA ΔkinB ΔkinC ΔgltA::neo N1802 → N635
N1878 ΔamyE::Psda-gfp (tet) This study
N1879 ΔamyE::Psda-gfp (tet) ΔgltA::cat N1878 → N694
N1876 ΔamyE::Pspo0E-gfp (tet) This study
N1877 ΔamyE::Pspo0E-gfp (tet) ΔgltA::cat N1876 → N694
N795 ΔcitZ::cat This study
N794 ΔcitB::cat This study
N1840 citZ::pMutinT3-hy (Pspac-hy-citZ operon, erm) This study
N1848 citZ::pMutinT3-hy (Pspac-hy-citZ operon, erm) ΔgltA::cat N1840 → N694
N1837 citB::pMutinT3-hy (Pspac-hy-citB, erm) This study
N1845 citB::pMutinT3-hy (Pspac-hy-citB, erm) ΔgltA::cat N1837 → N694
N1838 citC::pMutinT3-hy (Pspac-hy-icd-mdh, erm) This study
N1846 citC::pMutinT3-hy (Pspac-hy-icd-mdh operon, erm) ΔgltA::cat N1838 → N694
N1839 citG::pMutinT3-hy (Pspac-hy-citG, erm) This study
N1847 citG::pMutinT3-hy (Pspac-hy-citG, erm) ΔgltA::cat N1839 → N694
N1842 mdh::pMutinT3-hy (Pspac-hy-mdh, erm) This study
N1850 mdh::pMutinT3-hy (Pspac-hy-mdh, erm) ΔgltA::cat N1842→ N694
a

Arrows indicate B. subtilis transformation: donor strain → recipient strain.

Biofilm formation.

For pellicle biofilms, overnight cultures at 28°C in LB were diluted 100-fold, and 10 μl of each dilution was inoculated into 10 ml of 2× SGG in the wells of 6-well plates. For colony biofilms, 2 μl of the same dilutions were spotted onto 2× SGG 1.5% (wt/vol) agar or MSgg 1.5% (wt/vol) agar plates. These plates were incubated at 30°C. Biofilm formation tests were carried out at least three times, and representative examples are shown in the figures.

Growth curve analysis.

Wild-type and ΔgltA mutant strains grown at 30°C on LB plates overnight were inoculated into 5 ml of 2× SGG and grown at 37°C to the mid-exponential phase with vigorous shaking. These cultures were then added to 50 ml of prewarmed 2× SGG in a 500-ml baffled flask to yield an OD600 of 0.005. These cultures were shaken at 37°C, and the OD600 and pH were measured over time. The experiments were performed three times, and representative results are shown in the figures.

Flow cytometry analysis.

Pellicle biofilms grown in 5 ml of 2× SGG in 12-well plates were disrupted by pipetting, and 1 ml of the suspension was transferred to a 1.5 ml tube. Cells were pelleted by centrifugation at 17,400 × g for 2 min and then suspended in 1 ml phosphate-buffered saline (PBS) buffer. Cells were further dispersed by repetitive pipetting and then fixed for 7 min in 4% (wt/vol) paraformaldehyde (74). Prior to flow cytometry analysis, the cells were subjected to mild sonication to obtain single cells (74). Single cell fluorescence was measured and analyzed using an Accuri C6 Plus flow cytometer, and data were analyzed using BD Accuri C6 Plus software (BD Biosciences, Franklin Lakes, NJ). The number of recorded events was 50,000. Experiments were performed at least twice. Representative examples are shown in the figures.

Sporulation in pellicle biofilms.

Pellicles grown for 72 h in 5 ml of 2× SGG in 12-well plates were disrupted by repetitive pipetting. Next, 1 ml of the suspension was transferred to a 1.5-ml tube. Cells were then subjected to mild sonication to obtain single cells (74). The cell suspensions were used to count the number of CFU before and after heat treatment (80°C, 10 min). Sporulation frequency (%) ([number of heat-resistant spores/total number of cells] × 100) was calculated and expressed as the mean value from three independent experiments.

Supplementary Material

Supplemental file 1
JB.00120-20-s0001.pdf (672.9KB, pdf)

ACKNOWLEDGMENTS

We thank Nicola Stanley-Wall for kindly providing strains NRS2242 and NRS2394 and Hisaji Maki and Masahiro Akiyama for helpful advice and support.

K.K. was supported by JSPS KAKENHI (grant number JP17K07721).

Footnotes

Supplemental material is available online only.

REFERENCES

  • 1.Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108. doi: 10.1038/nrmicro821. [DOI] [PubMed] [Google Scholar]
  • 2.Branda SS, Vik S, Friedman L, Kolter R. 2005. Biofilms: the matrix revisited. Trends Microbiol 13:20–26. doi: 10.1016/j.tim.2004.11.006. [DOI] [PubMed] [Google Scholar]
  • 3.Flemming HC, Wingender J. 2010. The biofilm matrix. Nat Rev Microbiol 8:623–633. doi: 10.1038/nrmicro2415. [DOI] [PubMed] [Google Scholar]
  • 4.Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114–122. doi: 10.1038/nrd1008. [DOI] [PubMed] [Google Scholar]
  • 5.Mah TF, O’Toole GA. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39. doi: 10.1016/S0966-842X(00)01913-2. [DOI] [PubMed] [Google Scholar]
  • 6.Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP. 2001. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413:860–864. doi: 10.1038/35101627. [DOI] [PubMed] [Google Scholar]
  • 7.Schembri MA, Kjaergaard K, Klemm P. 2003. Global gene expression in Escherichia coli biofilms. Mol Microbiol 48:253–267. doi: 10.1046/j.1365-2958.2003.03432.x. [DOI] [PubMed] [Google Scholar]
  • 8.Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS. 2004. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186:4665–4684. doi: 10.1128/JB.186.14.4665-4684.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pisithkul T, Schroeder JW, Trujillo EA, Yeesin P, Stevenson DM, Chaiamarit T, Coon JJ, Wang JD, Amador-Noguez D. 2019. Metabolic remodeling during biofilm development of Bacillus subtilis. mBio 10:e00623-19. doi: 10.1128/mBio.00623-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Liu J, Prindle A, Humphries J, Gabalda-Sagarra M, Asally M, Lee DY, Ly S, Garcia-Ojalvo J, Süel GM. 2015. Metabolic co-dependence gives rise to collective oscillations within biofilms. Nature 523:550–554. doi: 10.1038/nature14660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen Y, Gozzi K, Yan F, Chai Y. 2015. Acetic acid acts as a volatile signal to stimulate bacterial biofilm formation. mBio 6:e00392. doi: 10.1128/mBio.00392-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Qin Y, He Y, She Q, Larese-Casanova P, Li P, Chai Y. 2019. Heterogeneity in respiratory electron transfer and adaptive iron utilization in a bacterial biofilm. Nat Commun 10:3702. doi: 10.1038/s41467-019-11681-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Branda SS, González-Pastor JE, Ben-Yehuda S, Losick R, Kolter R. 2001. Fruiting body formation by Bacillus subtilis. Proc Natl Acad Sci U S A 98:11621–11626. doi: 10.1073/pnas.191384198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Branda SS, González-Pastor JE, Dervyn E, Ehrlich SD, Losick R, Kolter R. 2004. Genes involved in formation of structured multicellular communities by Bacillus subtilis. J Bacteriol 186:3970–3979. doi: 10.1128/JB.186.12.3970-3979.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Branda SS, Chu F, Kearns DB, Losick R, Kolter R. 2006. A major protein component of the Bacillus subtilis biofilm matrix. Mol Microbiol 59:1229–1238. doi: 10.1111/j.1365-2958.2005.05020.x. [DOI] [PubMed] [Google Scholar]
  • 16.Romero D, Aguilar C, Losick R, Kolter R. 2010. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc Natl Acad Sci U S A 107:2230–2234. doi: 10.1073/pnas.0910560107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kobayashi K, Iwano M. 2012. BslA(YuaB) forms a hydrophobic layer on the surface of Bacillus subtilis biofilms. Mol Microbiol 85:51–66. doi: 10.1111/j.1365-2958.2012.08094.x. [DOI] [PubMed] [Google Scholar]
  • 18.Hobley L, Ostrowski A, Rao FV, Bromley KM, Porter M, Prescott AR, MacPhee CE, van Aalten DM, Stanley-Wall NR. 2013. BslA is a self-assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm. Proc Natl Acad Sci U S A 110:13600–13605. doi: 10.1073/pnas.1306390110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hamon MA, Stanley NR, Britton RA, Grossman AD, Lazazzera BA. 2004. Identification of AbrB-regulated genes involved in biofilm formation by Bacillus subtilis. Mol Microbiol 52:847–860. doi: 10.1111/j.1365-2958.2004.04023.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kearns DB, Chu F, Branda SS, Kolter R, Losick R. 2005. A master regulator for biofilm formation by Bacillus subtilis. Mol Microbiol 55:739–749. doi: 10.1111/j.1365-2958.2004.04440.x. [DOI] [PubMed] [Google Scholar]
  • 21.Chu F, Kearns DB, Branda SS, Kolter R, Losick R. 2006. Targets of the master regulator of biofilm formation in Bacillus subtilis. Mol Microbiol 59:1216–1228. doi: 10.1111/j.1365-2958.2005.05019.x. [DOI] [PubMed] [Google Scholar]
  • 22.Verhamme DT, Murray EJ, Stanley-Wall NR. 2009. DegU and Spo0A jointly control transcription of two loci required for complex colony development by Bacillus subtilis. J Bacteriol 191:100–108. doi: 10.1128/JB.01236-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Strauch M, Webb V, Spiegelman G, Hoch JA. 1990. The Spo0A protein of Bacillus subtilis is a repressor of the abrB gene. Proc Natl Acad Sci U S A 87:1801–1805. doi: 10.1073/pnas.87.5.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bai U, Mandic-Mulec I, Smith I. 1993. SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by protein-protein interaction. Genes Dev 7:139–148. doi: 10.1101/gad.7.1.139. [DOI] [PubMed] [Google Scholar]
  • 25.Chai Y, Chu F, Kolter R, Losick R. 2008. Bistability and biofilm formation in Bacillus subtilis. Mol Microbiol 67:254–263. doi: 10.1111/j.1365-2958.2007.06040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kobayashi K. 2008. SlrR/SlrA controls the initiation of biofilm formation in Bacillus subtilis. Mol Microbiol 69:1399–1410. doi: 10.1111/j.1365-2958.2008.06369.x. [DOI] [PubMed] [Google Scholar]
  • 27.Chai Y, Kolter R, Losick R. 2009. Paralogous antirepressors acting on the master regulator for biofilm formation in Bacillus subtilis. Mol Microbiol 74:876–887. doi: 10.1111/j.1365-2958.2009.06900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Chai Y, Kolter R, Losick R. 2010. Reversal of an epigenetic switch governing cell chaining in Bacillus subtilis by protein instability. Mol Microbiol 78:218–229. doi: 10.1111/j.1365-2958.2010.07335.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Verhamme DT, Kiley TB, Stanley-Wall NR. 2007. DegU co-ordinates multicellular behaviour exhibited by Bacillus subtilis. Mol Microbiol 65:554–568. doi: 10.1111/j.1365-2958.2007.05810.x. [DOI] [PubMed] [Google Scholar]
  • 30.Kobayashi K. 2007. Gradual activation of the response regulator DegU controls serial expression of genes for flagellum formation and biofilm formation in Bacillus subtilis. Mol Microbiol 66:395–409. doi: 10.1111/j.1365-2958.2007.05923.x. [DOI] [PubMed] [Google Scholar]
  • 31.Winkelman JT, Bree AC, Bate AR, Eichenberger P, Gourse RL, Kearns DB. 2013. RemA is a DNA-binding protein that activates biofilm matrix gene expression in Bacillus subtilis. Mol Microbiol 88:984–997. doi: 10.1111/mmi.12235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Molle V, Fujita M, Jensen ST, Eichenberger P, González-Pastor JE, Liu JS, Losick R. 2003. The Spo0A regulon of Bacillus subtilis. Mol Microbiol 50:1683–1701. doi: 10.1046/j.1365-2958.2003.03818.x. [DOI] [PubMed] [Google Scholar]
  • 33.Fujita M, González-Pastor JE, Losick R. 2005. High- and low-threshold genes in the Spo0A regulon of Bacillus subtilis. J Bacteriol 187:1357–1368. doi: 10.1128/JB.187.4.1357-1368.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Perego M, Cole SP, Burbulys D, Trach K, Hoch JA. 1989. Characterization of the gene for a protein kinase which phosphorylates the sporulation-regulatory proteins Spo0A and Spo0F of Bacillus subtilis. J Bacteriol 171:6187–6196. doi: 10.1128/jb.171.11.6187-6196.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Burbulys D, Trach KA, Hoch JA. 1991. Initiation of sporulation in B. subtilis is controlled by a multicomponent phosphorelay. Cell 64:545–552. doi: 10.1016/0092-8674(91)90238-T. [DOI] [PubMed] [Google Scholar]
  • 36.Trach KA, Hoch JA. 1993. Multisensory activation of the phosphorelay initiating sporulation in Bacillus subtilis: identification and sequence of the protein kinase of the alternate pathway. Mol Microbiol 8:69–79. doi: 10.1111/j.1365-2958.1993.tb01204.x. [DOI] [PubMed] [Google Scholar]
  • 37.Jiang M, Shao W, Perego M, Hoch JA. 2000. Multiple histidine kinases regulate entry into stationary phase and sporulation in Bacillus subtilis. Mol Microbiol 38:535–542. doi: 10.1046/j.1365-2958.2000.02148.x. [DOI] [PubMed] [Google Scholar]
  • 38.LeDeaux JR, Yu N, Grossman AD. 1995. Different roles for KinA, KinB, and KinC in the initiation of sporulation in Bacillus subtilis. J Bacteriol 177:861–863. doi: 10.1128/jb.177.3.861-863.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kobayashi K, Kuwana R, Takamatsu H. 2008. kinA mRNA is missing a stop codon in the undomesticated Bacillus subtilis strain ATCC 6051. Microbiology 154:54–63. doi: 10.1099/mic.0.2007/011783-0. [DOI] [PubMed] [Google Scholar]
  • 40.López D, Fischbach MA, Chu F, Losick R, Kolter R. 2009. Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis. Proc Natl Acad Sci U S A 106:280–285. doi: 10.1073/pnas.0810940106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.López D, Vlamakis H, Losick R, Kolter R. 2009. Cannibalism enhances biofilm development in Bacillus subtilis. Mol Microbiol 74:609–618. doi: 10.1111/j.1365-2958.2009.06882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.McLoon AL, Kolodkin-Gal I, Rubinstein SM, Kolter R, Losick R. 2011. Spatial regulation of histidine kinases governing biofilm formation in Bacillus subtilis. J Bacteriol 193:679–685. doi: 10.1128/JB.01186-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ohlsen KL, Grimsley JK, Hoch JA. 1994. Deactivation of the sporulation transcription factor Spo0A by the Spo0E protein phosphatase. Proc Natl Acad Sci U S A 91:1756–1760. doi: 10.1073/pnas.91.5.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Perego M, Hanstein C, Welsh KM, Djavakhishvili T, Glaser P, Hoch JA. 1994. Multiple protein-aspartate phosphatases provide a mechanism for the integration of diverse signals in the control of development in B. subtilis. Cell 79:1047–1055. doi: 10.1016/0092-8674(94)90035-3. [DOI] [PubMed] [Google Scholar]
  • 45.Burkholder WF, Kurtser I, Grossman AD. 2001. Replication initiation proteins regulate a developmental checkpoint in Bacillus subtilis. Cell 104:269–279. doi: 10.1016/s0092-8674(01)00211-2. [DOI] [PubMed] [Google Scholar]
  • 46.Carabetta VJ, Tanner AW, Greco TM, Defrancesco M, Cristea IM, Dubnau D. 2013. A complex of YlbF, YmcA and YaaT regulates sporulation, competence and biofilm formation by accelerating the phosphorylation of Spo0A. Mol Microbiol 88:283–300. doi: 10.1111/mmi.12186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.DeLoughery A, Dengler V, Chai Y, Losick R. 2016. Biofilm formation by Bacillus subtilis requires an endoribonuclease-containing multisubunit complex that controls mRNA levels for the matrix gene repressor SinR. Mol Microbiol 99:425–437. doi: 10.1111/mmi.13240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dubnau EJ, Carabetta VJ, Tanner AW, Miras M, Diethmaier C, Dubnau D. 2016. A protein complex supports the production of Spo0A-P and plays additional roles for biofilms and the K-state in Bacillus subtilis. Mol Microbiol 101:606–624. doi: 10.1111/mmi.13411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Tanner AW, Carabetta VJ, Martinie RJ, Mashruwala AA, Boyd JM, Krebs C, Dubnau D. 2017. The RicAFT (YmcA-YlbF-YaaT) complex carries two [4Fe-4S]2+ clusters and may respond to redox changes. Mol Microbiol 104:837–850. doi: 10.1111/mmi.13667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Morikawa M, Kagihiro S, Haruki M, Takano K, Branda S, Kolter R, Kanaya S. 2006. Biofilm formation by a Bacillus subtilis strain that produces gamma-polyglutamate. Microbiology 152:2801–2807. doi: 10.1099/mic.0.29060-0. [DOI] [PubMed] [Google Scholar]
  • 51.Kobayashi K. 2007. Bacillus subtilis pellicle formation proceeds through genetically defined morphological changes. J Bacteriol 189:4920–4931. doi: 10.1128/JB.00157-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Shemesh M, Chai Y. 2013. A combination of glycerol and manganese promotes biofilm formation in Bacillus subtilis via histidine kinase KinD signaling. J Bacteriol 195:2747–2754. doi: 10.1128/JB.00028-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hassanov T, Karunker I, Steinberg N, Erez A, Kolodkin-Gal I. 2018. Novel antibiofilm chemotherapies target nitrogen from glutamate and glutamine. Sci Rep 8:7097. doi: 10.1038/s41598-018-25401-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Belitsky BR. 2002. Biosynthesis of amino acids of the glutamate and aspartate families, alanine and polyamines, p 203–231. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and its closest relatives: from genes to cells. American Society for Microbiology, Washington, DC. [Google Scholar]
  • 55.Switzer RL, Zalkin HA, Saxild HH. 2002. Purine, pyrimidine, and pyridine nucleotide metabolism, p 255–269. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and its closest relatives: from genes to cells. American Society for Microbiology, Washington, DC. [Google Scholar]
  • 56.Gunka K, Commichau FM. 2012. Control of glutamate homeostasis in Bacillus subtilis: a complex interplay between ammonium assimilation, glutamate biosynthesis and degradation. Mol Microbiol 85:213–224. doi: 10.1111/j.1365-2958.2012.08105.x. [DOI] [PubMed] [Google Scholar]
  • 57.Fisher SH, Débarbouillé M. 2002. Nitrogen source utilization and its regulation, p 181–191. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and its closest relatives: from genes to cells, American Society for Microbiology, Washington, DC. [Google Scholar]
  • 58.Chagneau C, Saier MH Jr.. 2004. Biofilm-defective mutants of Bacillus subtilis. J Mol Microbiol Biotechnol 8:177–188. doi: 10.1159/000085790. [DOI] [PubMed] [Google Scholar]
  • 59.McLoon AL, Guttenplan SB, Kearns DB, Kolter R, Losick R. 2011. Tracing the domestication of a biofilm-forming bacterium. J Bacteriol 193:2027–2034. doi: 10.1128/JB.01542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Quisel JD, Burkholder WF, Grossman AD. 2001. In vivo effects of sporulation kinases on mutant Spo0A proteins in Bacillus subtilis. J Bacteriol 183:6573–6578. doi: 10.1128/JB.183.22.6573-6578.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gozzi K, Ching C, Paruthiyil S, Zhao Y, Godoy-Carter V, Chai Y. 2017. Bacillus subtilis utilizes the DNA damage response to manage multicellular development. NPJ Biofilms Microbiomes 3:8. doi: 10.1038/s41522-017-0016-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Reder A, Gerth U, Hecker M. 2012. Integration of σB activity into the decision-making process of sporulation initiation in Bacillus subtilis. J Bacteriol 194:1065–1074. doi: 10.1128/JB.06490-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Stanley NR, Britton RA, Grossman AD, Lazazzera BA. 2003. Identification of catabolite repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays. J Bacteriol 185:1951–1957. doi: 10.1128/jb.185.6.1951-1957.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Sonenshein AL. 2002. The Krebs citrate cycle, p 151–162. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and its closest relatives: from genes to cells. American Society for Microbiology, Washington, DC. [Google Scholar]
  • 65.Jin S, Sonenshein AL. 1994. Identification of two distinct Bacillus subtilis citrate synthase genes. J Bacteriol 176:4669–4679. doi: 10.1128/jb.176.15.4669-4679.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Kolodkin-Gal I, Elsholz AK, Muth C, Girguis PR, Kolter R, Losick R. 2013. Respiration control of multicellularity in Bacillus subtilis by a complex of the cytochrome chain with a membrane-embedded histidine kinase. Genes Dev 27:887–899. doi: 10.1101/gad.215244.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Arnaouteli S, Matoz-Fernandez DA, Porter M, Kalamara M, Abbott J, MacPhee CE, Davidson FA, Stanley-Wall NR. 2019. Pulcherrimin formation controls growth arrest of the Bacillus subtilis biofilm. Proc Natl Acad Sci U S A 116:13553–13562. doi: 10.1073/pnas.1903982116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Mhatre E, Troszok A, Gallegos-Monterrosa R, Lindstädt S, Hölscher T, Kuipers OP, Kovács ÁT. 2016. The impact of manganese on biofilm development of Bacillus subtilis. Microbiol 162:1468–1478. doi: 10.1099/mic.0.000320. [DOI] [PubMed] [Google Scholar]
  • 69.Jourlin-Castelli C, Mani N, Nakano MM, Sonenshein AL. 2000. CcpC, a novel regulator of the LysR family required for glucose repression of the citB gene in Bacillus subtilis. J Mol Biol 295:865–878. doi: 10.1006/jmbi.1999.3420. [DOI] [PubMed] [Google Scholar]
  • 70.Picossi S, Belitsky BR, Sonenshein AL. 2007. Molecular mechanism of the regulation of Bacillus subtilis gltAB expression by GltC. J Mol Biol 365:1298–1313. doi: 10.1016/j.jmb.2006.10.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Commichau FM, Herzberg C, Tripal P, Valerius O, Stülke J. 2007. A regulatory protein-protein interaction governs glutamate biosynthesis in Bacillus subtilis: the glutamate dehydrogenase RocG moonlights in controlling the transcription factor GltC. Mol Microbiol 65:642–654. doi: 10.1111/j.1365-2958.2007.05816.x. [DOI] [PubMed] [Google Scholar]
  • 72.Stannek L, Thiele MJ, Ischebeck T, Gunka K, Hammer E, Völker U, Commichau FM. 2015. Evidence for synergistic control of glutamate biosynthesis by glutamate dehydrogenases and glutamate in Bacillus subtilis. Environ Microbiol 17:3379–3390. doi: 10.1111/1462-2920.12813. [DOI] [PubMed] [Google Scholar]
  • 73.Pechter KB, Meyer FM, Serio AW, Stülke J, Sonenshein AL. 2013. Two roles for aconitase in the regulation of tricarboxylic acid branch gene expression in Bacillus subtilis. J Bacteriol 195:1525–1537. doi: 10.1128/JB.01690-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Vlamakis H, Aguilar C, Losick R, Kolter R. 2008. Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev 22:945–953. doi: 10.1101/gad.1645008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Murray EJ, Strauch MA, Stanley-Wall NR. 2009. σX is involved in controlling Bacillus subtilis biofilm architecture through the AbrB homologue Abh. J Bacteriol 191:6822–6832. doi: 10.1128/JB.00618-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Kobayashi K. 2019. Inactivation of cysL inhibits biofilm formation by activating the disulfide stress regulator Spx in Bacillus subtilis. J Bacteriol 201:e00712-18. doi: 10.1128/JB.00712-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Craig JE, Ford MJ, Blaydon DC, Sonenshein AL. 1997. A null mutation in the Bacillus subtilis aconitase gene causes a block in Spo0A-phosphate-dependent gene expression. J Bacteriol 179:7351–7359. doi: 10.1128/JB.179.23.7351-7359.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1
JB.00120-20-s0001.pdf (672.9KB, pdf)

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES